GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1) (Middle Region) Peptid
GABARAPL1
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN977193
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1) (Middle Region) Peptid (ABIN977193)
Target
GABARAPL1
(GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein Region
- Middle Region
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-GABARAPL1 antibody (Catalog #: ARP55399_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- GABARAPL1 (GABA(A) Receptor-Associated Protein Like 1 (GABARAPL1))
-
Hintergrund
-
GABARAPL1 increases cell-surface expression of kappa-type opioid receptor through facilitating anterograde intracellular trafficking of the receptor.
Alias Symbols: APG8L, ATG8, ATG8L, GEC1, ATG8B, APG8-LIKE
Protein Interaction Partner: CALCOCO2,OPRK1,SQSTM1,VDR,CALCOCO2,SQSTM1
Protein Size: 117 -
Molekulargewicht
- 14 kDa
-
Gen-ID
- 23710
-
NCBI Accession
- NM_031412, NP_113600
-
UniProt
- Q9H0R8
Target
-
Sie sind hier:
